just curious if anyone has an view on what the business would be valued at purely based on earnings and balance sheet . If you ignore past mess ups and the acquistion problems. to me EBITDA of 27mill with a market cap of 87mill or so seems incredible cheap... maybe the 70 mill in net debt is the worry.
i was in at 80cents so not sure if i am seeing massive value and a good turn around because of padt mistakes or it is objectively cheap right now
Ann: ENTERS JV - IN VITRO DIAGNOSTIC BLOOD BANK REAGENTS IN CHINA, page-16
Add PGC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.0¢ |
Change
-0.005(1.20%) |
Mkt cap ! $678.6M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 41.5¢ | 41.0¢ | $43.94K | 106.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 167425 | 41.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.5¢ | 369364 | 10 |
View Market Depth
| Last trade - 13.41pm 21/06/2024 (20 minute delay) ? |
| PGC (ASX) Chart |